Cures, jobs, ethics on the line in vote on stem cell research
By Megha Satyanarayana,
Detroit Free Press
| 09. 24. 2008
Opposing sides dig in as vote nears on Proposal 2
Ryan Dinkgrave lived a carefree life in Livonia until he was diagnosed with type I diabetes at age 10. Suddenly everything was ordered and careful.
"It makes you rethink everything you do," he said. "You're young, you're told you need to do shots, you're measuring your blood sugar. You have to count, carefully measure everything you eat."
Dinkgrave, now 25 and of Royal Oak, is among Michigan residents who support Proposal 2, a November ballot initiative allowing Michigan researchers to make embryonic stem cell cultures from excess embryos donated from fertility treatments. Researchers say the cells could unlock the secrets of disease and lead to cures for illnesses such as Alzheimer's and type I diabetes.
Voters will decide this emotionally charged issue on the basis of a 100-word ballot initiative -- one that could not only affect people's health, but also the economy of Michigan for decades to come. Proponents say the measure could spark a life sciences sector and pump billions of dollars into the state's struggling economy.
Opponents insist embryonic stem cell research is unnecessary because alternative types...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...